Clinical Trial Update: Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating N-acetylcysteine versus placebo for prevention of Sinusoidal Obstruction Syndrome in patients undergoing hematopoietic stem ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation
• Sinusoidal Obstruction Syndrome

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Instituto Brasileiro de Controle do Cancer | Conditions: Sinusoidal Obstruction Syndrome (SOS), Hematopoietic Stem Cell Transplant (HSCT) | Phase 2 | Status: UNKNOWN